Literature DB >> 24594482

Prostate-specific antigen screening in prostate cancer: perspectives on the evidence.

Timothy J Wilt1, Peter T Scardino, Sigrid V Carlsson, Ethan Basch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24594482      PMCID： PMC4200071          DOI： 10.1093/jnci/dju010

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  53 in total

1.  Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

Authors:  Jonas Hugosson; Sigrid Carlsson; Gunnar Aus; Svante Bergdahl; Ali Khatami; Pär Lodding; Carl-Gustaf Pihl; Johan Stranne; Erik Holmberg; Hans Lilja
Journal:  Lancet Oncol       Date:  2010-07-02       Impact factor: 41.316

2.  Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Authors:  Paul F Pinsky; Amanda Blacka; Barnett S Kramer; Anthony Miller; Philip C Prorok; Christine Berg
Journal:  Clin Trials       Date:  2010-06-22       Impact factor: 2.486

3.  Time trends and local variation in primary treatment of localized prostate cancer.

Authors:  Matthew R Cooperberg; Jeanette M Broering; Peter R Carroll
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

4.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

5.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

6.  Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.

Authors:  Andrew J Vickers; Angel M Cronin; Thomas Björk; Jonas Manjer; Peter M Nilsson; Anders Dahlin; Anders Bjartell; Peter T Scardino; David Ulmert; Hans Lilja
Journal:  BMJ       Date:  2010-09-14

7.  Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations.

Authors:  James A Eastham; Elyn Riedel; Peter T Scardino; Moshe Shike; Martin Fleisher; Arthur Schatzkin; Elaine Lanza; Lianne Latkany; Colin B Begg
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

Review 8.  Screening for breast cancer with mammography.

Authors:  Peter C Gøtzsche; Margrethe Nielsen
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

9.  Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer.

Authors:  Laurence Klotz; Liying Zhang; Adam Lam; Robert Nam; Alexandre Mamedov; Andrew Loblaw
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

10.  Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma.

Authors:  Jonas Hugosson; Gunnar Aus; Hans Lilja; Pär Lodding; Carl-Gustav Pihl
Journal:  Cancer       Date:  2004-04-01       Impact factor: 6.860
View more
  11 in total

1.  High PCA3 scores in urine correlate with poor-prognosis factors in prostate cancer patients.

Authors:  Wei Wei; Jiangyong Leng; Hongxiang Shao; Weidong Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Type of Insurance and Use of Preventive Health Services Among Older Adults in Mexico.

Authors:  Maricruz Rivera-Hernandez; Omar Galarraga
Journal:  J Aging Health       Date:  2015-03-24

Review 3.  Long non-coding RNAs and their potential impact on diagnosis, prognosis, and therapy in prostate cancer: racial, ethnic, and geographical considerations.

Authors:  Rebecca Morgan; Willian Abraham da Silveira; Ryan Christopher Kelly; Ian Overton; Emma H Allott; Gary Hardiman
Journal:  Expert Rev Mol Diagn       Date:  2021-11-25       Impact factor: 5.225

4.  Prostate cancer screening among family physicians in Ontario: An update on attitudes and current practice.

Authors:  Jason Paul Akerman; Christopher B Allard; Camilla Tajzler; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

5.  Comprehensive Analysis of Multiple Cohort Datasets Deciphers the Utility of Germline Single-Nucleotide Polymorphisms in Prostate Cancer Diagnosis.

Authors:  Wensheng Zhang; Yan Dong; Oliver Sartor; Kun Zhang
Journal:  Cancer Prev Res (Phila)       Date:  2021-04-17

6.  Are Men Making Informed Decisions According to the Prostate-Specific Antigen Test Guidelines? Analysis of the 2015 Behavioral Risk Factor Surveillance System.

Authors:  Dexter L Cooper; Latrice Rollins; Tanesha Slocumb; Brian M Rivers
Journal:  Am J Mens Health       Date:  2019 Mar-Apr

Review 7.  Detecting Tumor Metastases: The Road to Therapy Starts Here.

Authors:  M E Menezes; S K Das; I Minn; L Emdad; X-Y Wang; D Sarkar; M G Pomper; P B Fisher
Journal:  Adv Cancer Res       Date:  2016-08-17       Impact factor: 6.242

8.  Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia.

Authors:  Chun-Jen Hsiao; Tzong-Shin Tzai; Chein-Hung Chen; Wen-Horng Yang; Chung-Hsuan Chen
Journal:  Dis Markers       Date:  2016-03-15       Impact factor: 3.434

9.  CANcer-specific Evaluation System (CANES): a high-accuracy platform, for preclinical single/multi-biomarker discovery.

Authors:  Min-Seok Kwon; Seungyoon Nam; Sungyoung Lee; Young Zoo Ahn; Hae Ryung Chang; Yon Hui Kim; Taesung Park
Journal:  Oncotarget       Date:  2017-07-15

10.  Epidemiological and Economic Evaluation of a Pilot Prostate Cancer Screening Program.

Authors:  Dariga S Smailova; Elisa Fabbro; Serik E Ibrayev; Luca Brusati; Yuliya M Semenova; Umutzhan S Samarova; Farida S Rakhimzhanova; Sabit M Zhussupov; Zaituna A Khismetova; Hengameh Hosseini
Journal:  Prostate Cancer       Date:  2020-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.